Sulfonamide hydroxamic acids, a novel class of histone deacetylase inhibitors, are antiproliferative against human cancer cells

被引：0
|
作者：
Delorme, D
Lavoie, R
Bouchain, G
Frechette, S
Woo, SH
Abou Khalil, E
Leit, S
Fournel, M
Yan, PT
Trachy-Bourget, MC
Li, ZM
Besterman, J
机构：
[1] Methylgene Inc, Med Chem, Montreal, PQ H4S 2A1, Canada
[2] Methylgene Inc, Biol, Montreal, PQ H4S 2A1, Canada
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 223卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
217-MEDI
引用
收藏
页码：B135 / B135
页数：1
相关论文
共 50 条
  • [41] Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors
    Yan, Jiangkun
    Yue, Kairui
    Fan, Xuejing
    Xu, Ximing
    Wang, Jing
    Qin, Mengting
    Zhang, Qianer
    Hou, Xiaohan
    Li, Xiaoyang
    Wang, Yong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
  • [42] Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells
    Jeon, Heui Sook
    Ahn, Mee Young
    Park, Ji Hye
    Kim, Tae Hyung
    Chun, Pusoon
    Kim, Won Hee
    Kim, Jungsu
    Moon, Hyung Ryong
    Jung, Jee H.
    Kim, Hyung Sik
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (02) : 419 - 428
  • [43] Molecular modeling study of uracil-based hydroxamic acids-containing histone deacetylase inhibitors
    Sharma, Mukesh C.
    Sharma, Smita
    ARABIAN JOURNAL OF CHEMISTRY, 2019, 12 (08) : 2206 - 2215
  • [44] Histone deacetylase inhibitors: A novel class of therapeutic agents in diabetic nephropathy
    Lee, H. B.
    Noh, H.
    Seo, J. Y.
    Yu, M. R.
    Ha, H.
    KIDNEY INTERNATIONAL, 2007, 72 : S61 - S66
  • [45] tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells
    Valente, Sergio
    Trisciuoglio, Daniela
    Tardugno, Maria
    Benedetti, Rosaria
    Labella, Donatella
    Secci, Daniela
    Mercurio, Ciro
    Boggio, Roberto
    Tomassi, Stefano
    Di Maro, Salvatore
    Novellino, Ettore
    Altucci, Lucia
    Del Bufalo, Donatella
    Mai, Antonello
    Cosconati, Sandro
    CHEMMEDCHEM, 2013, 8 (05) : 800 - 811
  • [46] Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents
    El-Awady, Raafat
    Saleh, Ekram
    Hamoudi, Rifat
    Ramadan, Wafaa S.
    Mazitschek, Ralph
    Nael, Manal A.
    Elokely, Khaled M.
    Abou-Gharbia, Magid
    Childers, Wayne E.
    Srinivasulu, Vunnam
    Aloum, Lujain
    Menon, Varsha
    Al-Tel, Taleb H.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 42
  • [47] Growth inhibition of renal cancer cells by histone deacetylase inhibitors, suberoylanilide hydroxamic acid (SAHA) and PXD101
    Min, Gyeong Eun
    Hwang, Jung Jin
    Yoo, Changhee
    Kim, Mi-Joung
    Kim, Yong-Sook
    Song, Kanghyon
    Kim, Seong Cheol
    Kwon, Taek Min
    Park, Jong Yeon
    Ahn, Tai Young
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2008, 179 (04): : 40 - 40
  • [48] Differential transcriptional regulation of microRNAs, in ovarian cancer cells, by two distinct hydroxamic acid histone deacetylase inhibitors.
    Nageli, Kaleb
    Yoon, Seung Nam
    Thomson, J. Michael
    Reilly, Elizabeth
    Chen, Ching-Shih
    Hammond, Scott
    Nephew, Kenneth
    Balch, Curtis
    CANCER RESEARCH, 2009, 69
  • [49] Discovery of class I histone deacetylase inhibitors based on romidpesin with promising selectivity for cancer cells
    Zhang, Kuojun
    Yao, Yiwu
    Tu, Zhengchao
    Liao, Chenzhong
    Wang, Zhen
    Qiu, Yatao
    Chen, Dong
    Hamilton, Dale J.
    Li, Zheng
    Jiang, Sheng
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (04) : 311 - 324
  • [50] A promising future for breast cancer therapy with hydroxamic acid-based histone deacetylase inhibitors☆
    Das, Tanima
    Bhar, Sunandita
    Ghosh, Diya
    Kabi, Bikash
    Kar, Kanisha
    Chandra, Arpita
    BIOORGANIC CHEMISTRY, 2025, 156
12345